Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12594344 | Production of exosomes and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2042-12-02 | 0 | 31 |
| 12595246 | Crystalline and amorphous forms of N-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-07 | 2040-03-20 | 0 | 31 |
| 12595310 | Compositions and methods for transferrin receptor 1 targeting | 🖼🧊📄§ | 2026-04-07 | 2040-11-06 | 0 | 31 |
| 12595483 | Treatment of tumors with miRNA targeting CDK4/CDK6 | 🖼🧊📄§ | 2026-04-07 | 2043-11-16 | 0 | 31 |
| 12594343 | Treatment of cancer | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12595312 | CD133-binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-10-26 | 0 | 31 |
| 12595278 | Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway | 🖼🧊📄§ | 2026-04-07 | 2043-10-12 | 0 | 31 |
| 12595298 | Anti-NGF antibody and antigen-binding fragment thereof, preparation method, and application thereof | 🖼🧊📄§ | 2026-04-07 | 2041-08-02 | 0 | 31 |
| 12594259 | Treatment regimen for the treatment of neurological diseases or conditions | 🖼🧊📄§ | 2026-04-07 | 2040-10-29 | 0 | 31 |
| 12594263 | CBL inhibitors and compositions for expansion of immune cells | 🖼🧊📄§ | 2026-04-07 | 2040-09-23 | 0 | 31 |
| 12594274 | Method for preparing a crystalline form of rabeximod | 🖼🧊📄§ | 2026-04-07 | 2041-06-10 | 0 | 31 |
| 12594323 | Methods of reducing neuroinflammation | 🖼🧊📄§ | 2026-04-07 | 2043-04-13 | 0 | 31 |
| 12594291 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | 🖼🧊📄§ | 2026-04-07 | 2039-10-31 | 0 | 31 |
| 12594303 | Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis | 🖼🧊📄§ | 2026-04-07 | 2040-08-12 | 0 | 31 |
| 12594279 | Composition for preventing or treating TNF-α-related disease, comprising hydroflumethiazide as active ingredient | 🖼🧊📄§ | 2026-04-07 | 2041-11-05 | 0 | 31 |
| 12594285 | Compositions and methods for protecting against airborne pathogens and irritants | 🖼🧊📄§ | 2026-04-07 | 2041-10-08 | 0 | 31 |
| 12594257 | Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers | 🖼🧊📄§ | 2026-04-07 | 2042-06-02 | 0 | 31 |
| 12594348 | Compositions for treating Friedreich's ataxia | 🖼🧊📄§ | 2026-04-07 | 2040-12-18 | 0 | 31 |
| 12594249 | Soluble curcumin and its derivatives | 🖼🧊📄§ | 2026-04-07 | 2044-06-03 | 0 | 31 |
| 12594276 | Inhibitors of human immunodeficiency virus replication | 🖼🧊📄§ | 2026-04-07 | 2045-02-03 | 0 | 31 |
| 12595305 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2042-09-23 | 0 | 31 |
| 12594282 | Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury | 🖼🧊📄§ | 2026-04-07 | 2041-02-26 | 0 | 31 |
| 12594278 | Method for treatment of muscular dystrophy | 🖼🧊📄§ | 2026-04-07 | 2040-07-16 | 0 | 31 |
| 12594283 | Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug | 🖼🧊📄§ | 2026-04-07 | 2040-10-26 | 0 | 31 |
| 12594258 | Inhibitors of MHC-I Nef downmodulation for treating HIV | 🖼🧊📄§ | 2026-04-07 | 2040-12-16 | 0 | 31 |
| 12594280 | Antiviral compositions for treating the flu | 🖼🧊📄§ | 2026-04-07 | 2042-05-31 | 0 | 31 |
| 12596122 | LILRB2 antibodies and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12594281 | Pharmaceutical dosage forms and methods of use | 🖼🧊📄§ | 2026-04-07 | 2045-05-16 | 0 | 31 |
| 12594261 | Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 🖼🧊📄§ | 2026-04-07 | 2039-12-14 | 0 | 31 |
| 12594317 | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method, and use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-11-13 | 0 | 31 |
| 12594253 | HIV inhibitors | 🖼🧊📄§ | 2026-04-07 | 2039-07-24 | 0 | 31 |
| 12595302 | CLDN18.2 binding molecule | 🖼🧊📄§ | 2026-04-07 | 2040-05-21 | 0 | 31 |
| 12594252 | Methods for treating inflammatory skin conditions | 🖼🧊📄§ | 2026-04-07 | 2042-06-20 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |
| 12595232 | DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor | 🖼🧊📄§ | 2026-04-07 | 2041-02-16 | 0 | 31 |
| 12594248 | Stress management in human subjects in need thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-13 | 0 | 31 |
| 12590156 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2041-02-05 | 0 | 31 |
| 12589088 | Compositions and methods for treating cancer with andrographolide and melatonin combination therapy | 🖼🧊📄§ | 2026-03-31 | 2041-04-30 | 0 | 31 |
| 12590103 | Polymorph of EP4 receptor antagonist, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-01-29 | 0 | 31 |
| 12589144 | Combined norovirus and rotavirus vaccine composition and methods of preparation | 🖼🧊📄§ | 2026-03-31 | 2041-01-06 | 0 | 31 |
| 12589112 | Oncolytic virus compositions including IL-15 complex and methods for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-01-22 | 0 | 31 |
| 12589094 | Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 | 🖼🧊📄§ | 2026-03-31 | 2044-02-28 | 0 | 31 |
| 12590124 | Peptide with neutralizing activity against severe acute respiratory syndrome coronavirus 2 | 🖼🧊📄§ | 2026-03-31 | 2041-07-15 | 0 | 31 |
| 12590141 | Monoclonal antibodies against Henipavirus glycoprotein G and encoding nucleic acids thereof | 🖼🧊📄§ | 2026-03-31 | 2041-06-27 | 0 | 31 |
| 12589113 | Preparation of a therapeutic composition for treating autoimmune diseases | 🖼🧊📄§ | 2026-03-31 | 2044-10-01 | 0 | 31 |
| 12590165 | Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B | 🖼🧊📄§ | 2026-03-31 | 2041-03-05 | 0 | 31 |
| 12590145 | Bi-specific chimeric antigen receptor | 🖼🧊📄§ | 2026-03-31 | 2041-05-18 | 0 | 31 |
| 12590148 | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2039-11-22 | 0 | 31 |
| 12589161 | PEGylated synthetic KL4 peptide, compositions and methods thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-10 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |